MeSH term
Frequency | Condition_Probility | Animals | 62 | 0.0 |
Cells, Cultured | 17 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Male | 20 | 0.0 |
Mice | 39 | 0.0 |
Mice, Inbred C57BL | 6 | 0.0 |
*Neoplasm Proteins | 41 | 5.0 |
Oxidation-Reduction | 2 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Rats | 18 | 0.0 |
Research Support, Non-U.S. Gov't | 81 | 0.0 |
Transcription Factors/genetics/*physiology | 4 | 2.0 |
Transcription, Genetic | 6 | 0.0 |
Antibody Specificity | 2 | 0.0 |
Cell Line | 14 | 0.0 |
DNA-Binding Proteins/metabolism | 7 | 0.0 |
Humans | 81 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Protein Binding | 11 | 0.0 |
Transcription Factors/*metabolism | 5 | 0.0 |
Casein Kinase II | 3 | 2.0 |
Molecular Sequence Data | 23 | 0.0 |
Phosphorylation | 5 | 0.0 |
Proteasome Endopeptidase Complex | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Repressor Proteins/genetics/*metabolism | 2 | 1.0 |
Transcription Factors/genetics/*metabolism | 9 | 1.0 |
Two-Hybrid System Techniques | 4 | 0.0 |
Blotting, Western | 8 | 0.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Cyclins/metabolism | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 6 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Helix-Loop-Helix Motifs/genetics | 7 | 17.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 9 | 0.0 |
Up-Regulation/drug effects | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Immunohistochemistry | 16 | 0.0 |
*Repressor Proteins | 31 | 2.0 |
Base Sequence | 20 | 0.0 |
Cell Differentiation/*drug effects | 2 | 1.0 |
Enzyme Activation | 3 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Tumor Cells, Cultured | 13 | 0.0 |
Dimerization | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 37 | 0.0 |
Transfection | 15 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
Blotting, Northern | 12 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 4 | 4.0 |
Helix-Loop-Helix Motifs | 15 | 6.0 |
Phylogeny | 2 | 0.0 |
RNA, Messenger/metabolism | 9 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Time Factors | 4 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Transcription Factors/*biosynthesis/genetics | 3 | 3.0 |
Cell Differentiation | 15 | 0.0 |
*Nerve Tissue Proteins | 3 | 0.0 |
Signal Transduction | 6 | 0.0 |
T-Lymphocytes/cytology/immunology | 2 | 2.0 |
*Helix-Loop-Helix Motifs | 9 | 9.0 |
In Situ Hybridization | 8 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Astrocytes/metabolism | 3 | 4.0 |
Cell Division/physiology | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Gene Expression Regulation/physiology | 2 | 0.0 |
Oligodendroglia/metabolism | 2 | 4.0 |
Phenotype | 5 | 0.0 |
Transcription Factors/*genetics | 10 | 0.0 |
Adult | 8 | 0.0 |
Female | 19 | 0.0 |
Middle Aged | 7 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Repressor Proteins/biosynthesis/genetics | 2 | 18.0 |
DNA-Binding Proteins/genetics | 4 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Aged | 4 | 0.0 |
Comparative Study | 10 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Up-Regulation/genetics | 2 | 2.0 |
*Algorithms | 4 | 6.0 |
Reproducibility of Results | 3 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
Cell Division | 7 | 0.0 |
Muscle, Smooth, Vascular/cytology/*metabolism | 2 | 9.0 |
Transcription Factors/biosynthesis/*genetics/metabolism | 2 | 22.0 |
Bone Morphogenetic Proteins/*metabolism | 2 | 4.0 |
Cell Lineage | 3 | 0.0 |
Pregnancy | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Gene Expression Regulation/*drug effects | 3 | 0.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
Molecular Weight | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 3 | 0.0 |
Mice, Knockout | 5 | 0.0 |
Mice, Transgenic | 5 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Transduction, Genetic | 3 | 0.0 |
Transforming Growth Factor beta/*pharmacology | 3 | 0.0 |
Chromosomes, Human, Pair 1/*genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 3 | 0.0 |
*Apoptosis | 2 | 0.0 |
Heat-Shock Proteins 90/genetics | 2 | 33.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Transcription Factors/genetics | 4 | 0.0 |
B-Lymphocytes/cytology | 2 | 2.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Neurons/metabolism | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/genetics/metabolism | 2 | 1.0 |
Exons | 2 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Cell Differentiation/*physiology | 3 | 1.0 |
Transcription Factors/genetics/metabolism | 3 | 0.0 |
Algorithms | 7 | 1.0 |
Decision Support Techniques | 3 | 16.0 |
Acute Disease | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Prospective Studies | 3 | 0.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/genetics | 2 | 1.0 |
Gene Expression | 7 | 0.0 |
Thymus Gland/*cytology | 2 | 3.0 |
Gene Expression Regulation, Developmental/genetics | 2 | 2.0 |
Helix-Loop-Helix Motifs/*genetics | 5 | 13.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
3T3 Cells | 6 | 0.0 |
Cell Differentiation/genetics | 3 | 1.0 |
Cyclic AMP/pharmacology | 2 | 1.0 |
Genes, Reporter | 2 | 0.0 |
DNA, Complementary/analysis/chemistry | 2 | 33.0 |
Fetal Hemoglobin/genetics | 2 | 50.0 |
Gene Expression Regulation | 9 | 0.0 |
Genes, Switch | 2 | 18.0 |
Globins/biosynthesis/*genetics | 2 | 15.0 |
K562 Cells | 2 | 0.0 |
Leukemia, Erythroblastic, Acute/*genetics/pathology | 3 | 37.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Sequence Analysis, RNA | 2 | 5.0 |
Binding Sites | 4 | 0.0 |
DNA Primers | 3 | 0.0 |
*Transcription Factors | 4 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Gene Expression Regulation/genetics | 2 | 1.0 |
Retroviridae/genetics | 2 | 0.0 |
Thymus Gland | 2 | 10.0 |
Reference Values | 2 | 0.0 |
*Artificial Intelligence | 4 | 36.0 |
Biopsy | 2 | 0.0 |
*Decision Trees | 6 | 85.0 |
*Diagnosis, Computer-Assisted | 5 | 55.0 |
Liver/pathology | 2 | 1.0 |
Liver Diseases/*diagnosis | 2 | 28.0 |
Culture Media, Serum-Free | 2 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Cell Survival | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
RNA/metabolism | 2 | 0.0 |
RNA Splicing | 2 | 0.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
Cell Cycle | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Consensus Sequence | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Neuroblastoma/*genetics | 2 | 2.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Cell Cycle/*physiology | 2 | 0.0 |
Helix-Loop-Helix Motifs/genetics/physiology | 2 | 40.0 |
Mutation | 2 | 0.0 |
Fetus | 2 | 0.0 |
Binding Sites/genetics | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
*Expert Systems | 3 | 42.0 |
COS Cells | 2 | 0.0 |
Cell Division/genetics | 2 | 0.0 |
Down-Regulation | 4 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Expert Systems | 3 | 75.0 |
Information Systems | 2 | 10.0 |
B-Lymphocytes/metabolism | 2 | 1.0 |
*Logistic Models | 2 | 22.0 |
Plasmids/metabolism | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Breast Neoplasms/genetics | 2 | 0.0 |
Up-Regulation | 4 | 0.0 |
Evaluation Studies | 2 | 0.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
